Research Ⅲ on the Changes of Sponsors and Production Sites during the Clinical Research Phase of Drugs: The Enlightenment of the Requirements for Drug Clinical Trials and Change Management during Clinical Trials in the United States on Improving China's Regulatory System
Yu Bing, Wu Zhengyu, Chen Jiangpeng, Chen Yuan, Wang Fangmin
Chinese Pharmaceutical Affairs . 2024, (5): 508 -515 .  DOI: 10.16153/j.1002-7777.2024.05.003

京ICP备17052540号-7
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.